These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4907894)

  • 1. [Appearance of circulating, precipiting antibodies, horse antiproteins in patients with renal grafts treated with antilymphocyte serum].
    Druet P; Bariéty J; Lagrue G; Idatte JM
    J Urol Nephrol (Paris); 1969 Dec; 75(12):999-1005. PubMed ID: 4907894
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic responses of graft recipients to antilymphocyte globulin: effect of prior treatment with aggregate-free gamma globulin.
    Weksler ME; Bull G; Schwartz GH; Stenzel KH; Rubin AL
    J Clin Invest; 1970 Aug; 49(8):1589-95. PubMed ID: 4194090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antilymphocyte serum (ALS) as an immunosuppressive agent in transplantation of the canine larynx. II. Purification of antibodies.
    Mogi G; Harvey JE; Ohyama M; Ueda N; Ogura JH
    Laryngoscope; 1972 Feb; 82(2):252-64. PubMed ID: 4622551
    [No Abstract]   [Full Text] [Related]  

  • 4. The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients.
    Amemiya H; Yokoyama T; Putnam CW; Torisu M; Starzl TE
    Clin Exp Immunol; 1972 Mar; 10(3):417-26. PubMed ID: 4556008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenic components of equine anti-human lymphocyte lobulin in renal allograft recipients.
    Wolf RE; Remmers AR; Sarles HE; Fish JC; Lindley JD; Vyvial TM; Ritzmann SE
    Clin Exp Immunol; 1972 Feb; 10(2):235-41. PubMed ID: 4558408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permanent survival of dog renal allografts after a limited course of antilymphocyte serum treatment.
    Shanfield I; Wren SF; Blennerhassett JB
    Surg Forum; 1969; 20():304-5. PubMed ID: 4910606
    [No Abstract]   [Full Text] [Related]  

  • 7. ALG treatment of Rhesus monkeys. Attempts to reduce complications by the induction of tolerance.
    Balner H; Yron I; Dersjant H; Zaalberg O; Betel I
    Transplantation; 1970 Nov; 10(5):416-24. PubMed ID: 4992451
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation.
    Cerilli GJ; Miller A; Hattan D
    Surg Forum; 1970; 21():250-2. PubMed ID: 4936976
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of tolerance to antilymphocyte globulin in man.
    Weksler ME; Bull G; Schwartz GH; Stenzel KH; Rubin AL
    Transplant Proc; 1971 Mar; 3(1):754-7. PubMed ID: 4937967
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-reactivity studies of horse, goat and rabbit anti-lymphocyte globulin.
    Ameniya H; Kashiwagi N; Putnam CW; Starzl TE
    Clin Exp Immunol; 1970 Feb; 6(2):279-89. PubMed ID: 4985160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing effectiveness of antilymphocytic globulin by prevention of antibody formation to horse IgG.
    Butler WT; Rossen RD
    Transplant Proc; 1971 Mar; 3(1):733-6. PubMed ID: 4999467
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic enhancement of renal allografts in the rat. I. Dissociation of graft survival and antibody response.
    Lucas ZJ; Markley J; Travis M
    Fed Proc; 1970; 29(6):2041-7. PubMed ID: 4921562
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the mechanism of rejection of tolerated skin homografts and abrogation of immunological tolerance by hyperimmune serum.
    Hasek M; Skamene E; Karakoz I; Chutná J; Nouza K; Bubeník J; Sovová V; Nĕmec M; Jonák J
    Folia Biol (Praha); 1968; 14(6):411-24. PubMed ID: 4236901
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of antilymphocyte serum in organ and tissue allotransplantation (survey of the literature)].
    Korenevskaia VA; Shumakov VI
    Khirurgiia (Mosk); 1972 Feb; 49(2):127-31. PubMed ID: 4572233
    [No Abstract]   [Full Text] [Related]  

  • 15. Glomerular basement membrane--reactive antibody in anti-lymphocyte globulin.
    Wilson CB; Dixon FJ; Fortner JG; Cerilli GJ
    J Clin Invest; 1971 Jul; 50(7):1525-35. PubMed ID: 4996886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune tolerance and antilymphocyte sera].
    Kaden J
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):522-8. PubMed ID: 5000438
    [No Abstract]   [Full Text] [Related]  

  • 17. The immunosuppressive properties of sub-fractions of antilymphocytic IgG of equine origin.
    James K; Pullar DM; Brydon J
    Immunology; 1971 Aug; 21(2):247-57. PubMed ID: 5571539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antilymphocyte serum: present status.
    Shanfield I; MacLean LD
    Can Med Assoc J; 1969 May; 100(20):925-30. PubMed ID: 4890848
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation and characterization of antibodies and other immunologically reactive substances from rejecting renal allografts.
    Hampers CL; Kolker P; Hager EB
    J Immunol; 1967 Sep; 99(3):514-25. PubMed ID: 4860923
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating immune complexes in renal transplanted patients.
    Vincent C; Fortier M; Revillard JP; Traeger J
    Transplant Proc; 1979 Jun; 11(2):1274-5. PubMed ID: 382507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.